"Dexcom: Wedbush continues to believe DexCom is the best positioned CGM pure play (13.09 -0.05)
Wedbush continues to believe DexCom is the best positioned pure play company to capitalize on the growing CGM market. Firm says despite recent regulatory setbacks, they are comfortable with the revised product timelines. In the meantime, they view the higher regulatory hurdle for all CGM products as a barrier to entry for potential competitors whereas DexCom already has a marketed product. Looking out longer term, firm believes DexCom's fourth and fifth generation sensors will continue to lead the industry in terms of technology as initial data for both have shown improvements in a number of aspects including performance".